Imaging Endpoints

About Imaging Endpoints

Imaging Endpoints sits in CRO / Clinical Trials, a segment Bracken sees as structurally important to the radiopharma value chain.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• Reuters Health · 2026-01-20
  Imaging Endpoints expands cyclotron capacity to meet Lu-177 demand
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Endpoints News · 2026-02-11
  Imaging Endpoints announces Phase II readout for lead theranostic candidate
  Coverage notes the company's growing footprint in the radioligand therapy space.
• FierceBiotech · 2026-11-22
  Imaging Endpoints appoints new Chief Medical Officer ahead of pivotal trial
  The announcement comes amid tightening Mo-99 and Lu-177 supply.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.